The United Nations Office at Geneva
Multimedia Newsroom
Edited News | WHO , UNOG , UNITED NATIONS
Bi-weekly Press Briefing: Regeneron COVID-19 Treatment - WHO
WHO back Regeneron COVID-19 drug cocktail, but calls for access and reduction on price
The Regeneron antibody-drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for people with COVID-19, the UN agency said on Friday, before underscoring the need for lower prices and equitable distribution.
“This is a major breakthrough in the care of COVID-19 patients” said Dr Janet Diaz, WHO head of clinical care. “This is our first recommendation for a therapeutic for those patients with mild, moderate disease,” she said, because it reduces “the need for hospitalisation if they are at high risk”.
WHO’s conditional recommendations are for use of the drug combination on patients who were not severely ill but at high risk of being admitted to hospital with COVID-19, or those with severe cases of the disease and no existing antibodies.
“Giving them this additional antibody seems to show an effect. And what effect is that? A reduction in mortality” Dr Diaz told a briefing in Geneva.
The antibody therapy was granted emergency use authorization in the United States November last year after it was used to treat former President Donald Trump when he was admitted to hospital with COVID-19.
The United Kingdom has also approved Regeneron, while it is under review in Europe. The WHO recommendations were largely based on data from a British study of 9,000 patients in June which found that the therapy reduced deaths in hospitalised patients whose own immune systems had failed to produce a response.
“We are taking the information (from the UK study) and generalizing it to other persons,” said Dr Diaz. “We saw there was a benefit we thought was meaningful.” The treatment has been on the market for decades to treat many other diseases, including cancers. It is based on a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the human body to fight off infections.
Swiss drugmaker Roche has been working in partnership with Regeneron, which holds the patent, to produce the antibody treatment. Dr Diaz urged Regeneron to lower the drug’s price and work on equitable distribution worldwide: “We know that the life-saving benefits and the benefits for patients with COVID-19 is significant and requires action.” Dr Diaz added that UNITAID, an international health agency, was negotiating directly with Roche for lower prices and equitable distribution across all parts of the world, “including low and middle-income countries”.
WHO has also been in discussions with the company for a donation and distribution of the drug through UN Children’s Fund UNICEF, following an allocation criteria set by the health agency. “We are working together with the company so we can address these very important issues so we can have equitable access” she said.
In a statement, WHO said in parallel it had “launched a call to manufacturers who may wish to submit their products for pre-qualification, which would allow for a ramping-up of production and therefore greater availability of the treatment and expanded access. ACT-A partners are also working with WHO on an equitable access framework for recommended COVID-19 therapeutics”. On that subject, Dr Diaz added that “there are bottlenecks and we are aware of those. WHO has launched the pre-qualification expression of interest call so that the manufacturing companies can start to submit their dossiers to WHO”.
ends
STORY: Regeneron COVID-19 Treatment - WHO
TRT: 2’18’’
SOURCE: UNTV CH
LANGUAGE: ENGLISH
ASPECT RATIO: 16:19
DATELINE: 24 Sept 2021, GENEVA, Switzerland
SHOTLIST
- Exterior wide shot, United Nations flag alley.
- Wide shot, inside the bi-weekly press conference room, participants.
- SOUNDBITE (English): Dr Janet Diaz, Head of Clinical Care, World Health Organization (WHO): “So this is a major breakthrough in the care of COVID-19 patients, we have expanded our tools to treat patients with covid-19 and this is our first recommendation for a therapeutic for those patients with mild, moderate disease because of the risk of reducing the need for hospitalization if they are at high risk.”
- Medium shot, participant attending the press briefing.
- SOUNDBITE (English): Dr Janet Diaz, Head of Clinical Care, World Health Organization (WHO): “The first recommendation is a conditional recommendation for use in patients who have non severe COVID-19, so those are patients that are mild or moderate and can be seen in the outpatient setting, but it's on the condition that patients are at the higher risk for severe disease. So not for all the patients, but those at the highest risk.”
- Medium shot, participant attending the briefing.
- SOUNDBITE (English): Dr Janet Diaz, Head of Clinical Care, World Health Organization (WHO): “The second recommendation is a conditional recommendation for patients with severe and critical COVID-19, so those are the sicker patients in the hospital on oxygen, on corticosteroids. The condition here is for those patients that are sero-negative. That means on a serology test at that moment, they have not yet mounted their own antibody response. So giving them this additional antibody seems to show an effect. And what effect is that? A reduction in mortality.”
- Wide shot, speakers at podium and briefing broadcast on large-screen TV.
- SOUNDBITE (English): Dr Janet Diaz, Head of Clinical Care, World Health Organization (WHO): “It is true right now there's limited availability and the cost is high for this monoclonal antibody cocktail. However, with this new recommendation, we know that the life-saving benefits and the benefits for patients with COVID-19 is significant and requires action.”
- Medium shot, participant attending the briefing, podium speaker to rear.
- SOUNDBITE (English): Dr Janet Diaz, Head of Clinical Care, World Health Organization (WHO): “At this time, through the ACT aid mechanism UNITAID is negotiating directly with Roche pharmaceutical companies about manufacturing drugs for lower prices, as you have just described, is very important and equitable distribution across all the regions, including low and middle-income countries.”
- Wide shot, briefing room, the three main speakers of the briefing.
- Medium shot, participants in foreground and to rear.
- Wide shot, press briefing room.
Similar Stories
1
1
1
Edited News | UNICEF
Somalia: child hunger surges as humanitarian aid dries up – UNICEF
The global funding crisis for vital lifesaving work is taking a growing toll on the most vulnerable children in Somalia, where hundreds of health and nutrition facilities have been forced to close, the UN Children’s Fund (UNICEF) warned on Friday
1
1
1
Edited News | OCHA
As the deadliest Ebola outbreak in DR Congo’s history continued spreading on Friday, UN responders renewed their urgent appeal for immediate international support, with existing funding for lifesaving work critically low.
1
1
1
Edited News | WHO
DRC: In the fight against Ebola, bikers transporting dead bodies hold key to community engagement - WHO
From the frontlines of the deadliest-ever Ebola Bundibugyo outbreak in the Democratic Republic of the Congo (DRC), the UN’s World Health Organization (WHO) shared details on Tuesday of a massive push for community engagement, a day after yet another ambulance attack.
1
1
1
Edited News | UNFPA
Sudan: The harrowing reality of giving birth in a war zone
Sudanese women about to give birth are losing their babies and sometimes their own lives because of a lack of specialist healthcare support, amid the ongoing war, UN humanitarians said on Friday.
1
1
1
Edited News | OCHA , WHO
Colombia earthquake: International teams ready to support, says UN
As earthquake rescue efforts across western Colombia continued on Tuesday, UN agencies said that they stood ready to help “with everything we've got” if and when the request came from the authorities.
2
1
2
Edited News , Press Conferences | HRC
Myanmar's military has carried out a sustained campaign of deliberate attacks on civilians – including airstrikes on homes, schools and camps for displaced people, alongside arbitrary detention, torture and sexual violence – Human Rights Council-appointed investigators said on Tuesday.
1
6
1
1
Edited News | UNOG
In a new twist on panda diplomacy, UN Geneva welcomed five young peacocks to the Palace of Nations on Friday, a gift of India that preserves a tradition of keeping the stately birds in the grounds, that predates both the global body and its ill-fated predecessor, the League of Nations.
1
1
1
Edited News | WFP
Afghanistan’s hunger crisis intensifies as millions go without food aid – WFP
Afghanistan’s dire hunger crisis now affects 14 million people including babies fed on weak tea and a little bread by their despairing and dirt-poor parents.
In a new alert on Tuesday, the UN World Food Programme (WFP) said that one in three Afghans is now in the grip of acute food insecurity and that it lacks the resources to contain the deepening crisis.
1
1
2
Edited News | IOM
From fake jobs to forced crime: IOM sounds alarm on human trafficking behind online scams
A job offer can conceal a criminal network and a single click can lead to a nightmare. Lured by false promises of legitimate employment abroad, hundreds of thousands of people are being trafficked each year, held captive and forced to carry out online scams.
Ahead of World Day Against Trafficking in Persons marked on 30 July, the International Organization for Migration (IOM) is raising the alarm over a rapidly expanding multibillion-dollar criminal industry that turns job seekers into victims of forced cybercrime.
1
1
1
Edited News | UN WOMEN
In Sudan’s El Obeid, women risk drone attacks by day and rape by night to access water
As war intensifies in the city of El Obeid in North Kordofan state, filling up a jerrycan of water comes at a high risk for women and girls: by day, drones strike water points and by night, women who venture out to fill a bucket risk rape. UN Women warns of a dual terror that has turned access to water into a deadly gamble.
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights spokesperson Shabia Mantoo made the following remarks on stranded Hormuz seafarers abandoned for months at sea, at the bi-weekly press briefing in Geneva.
1
1
1
Edited News | OHCHR , UNOG
At the bi-weekly press conference in Geneva, Thameen Al-Kheetan, spokesperson for the Office of the UN High Commissioner for Human Rights, and Danielle Bell, head of UN Human Rights’ Ukraine team, spoke of the deepening impact of the war on the civilian population.